Moreover, in vivo experiments demonstrated that SRSF6 overexpression reversed the enhanced drug sensitivity observed in NSUN2-knockout cells, leading to tumor growth and final tumor weights comparable to those of NSUN2-knockout controls (Figure 6N-S). Here, SRSF6 is linked to neoplasm.